Ignite Creation Date:
2024-05-06 @ 3:10 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02229149
Status:
TERMINATED
Last Update Posted:
2022-12-02
First Post:
2014-08-27
Brief Title:
Phase 2 Study of Standard Chemotherapy With Trastuzumab Plus or Minus Pertuzumab for Pre-treated Metastatic Breast Cancer
Sponsor:
US Oncology Research
Organization:
US Oncology Research